UPDATED 2:00 PM PT – Saturday, September 5, 2020
Pfizer, Johnson and Johnson, Moderna and many other pharmaceutical companies are preparing a joint statement. They are hoping to assure Americans any vaccine created to protect U.S. citizens will undergo a rigorous vetting process before release.
The joint pledge will create an agreement between the competing companies. Each entity will agree not to seek premature approval for any preventative measure from the government until they meet safety standards.
Many have raised concerns over the effectiveness of a COVID vaccine, which is expected to be available before the end of the year. The FDA was rumored to have made a similar declaration, in which it pledged to not approve any vaccine unless safety measures were thoroughly met.
Concerns surfaced after the CDC began urging states to prepare for distributions by November 1st.
The White House recently shut down claims the move was an attempt to boost voters for President Trump’s reelection. The Department of Health and Human Services also issued a statement, assuring the public the development of the vaccine has nothing to do with the election.
“You had Dr. Hahn who said this: ‘I can assure you 100% that the president has never pressured me to make a decision regarding any regulatory aspect of the FDA’s work.’ He said that just a few months ago, it is absolutely the case. You had Secretary Azar saying this morning about the vaccine whether it’s October 15th, November 1st or November 15th, this is all about saving lives.” – Kayleigh McEnany, White House Press Secretary
Vaccine development began advancing rapidly as scientists learned more about the coronavirus.
One of the companies taking part in the pledge, Pfizer, stated they will have the results of their last phase clinical trials by next month. Several pharmaceutical companies hope to continue the trial process and deliver a vaccine by the end of the year.